21 May 2009
GlaxoSmithKline (GSK) has offered to donate 50 million doses of a pandemic vaccine to the World Health Organisation in the event of a global flu outbreak.
The offer was made during a meeting between UN officials, vaccine makers and othre health experts to discuss how to provide vaccines to poor countries if the swine flu outbreak goes global.
No pandemic vaccine exists yet, byt pharma companies claim they can begin production immediately once they get the vaccine's key ingredient, a 'seed stock' based on the virus. That is being developed by the Unites States's Centers for Disease Prevention and Control and should be available by mid-July.
GSK has already signed agreements with various countries to provide them with pandemic vaccine as soon as it becomes available. These include the UK, Belgium and Finland.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.